DEMARZO, MARIA GIULIA
 Distribuzione geografica
Continente #
EU - Europa 1.594
AS - Asia 19
SA - Sud America 11
Totale 1.624
Nazione #
IT - Italia 1.594
CN - Cina 10
BR - Brasile 8
VN - Vietnam 5
AR - Argentina 2
ID - Indonesia 2
AZ - Azerbaigian 1
HK - Hong Kong 1
VE - Venezuela 1
Totale 1.624
Città #
Genoa 768
Genova 552
Vado Ligure 146
Rapallo 126
Ho Chi Minh City 4
Beijing 3
Bordighera 2
Aguilares 1
Baku 1
Barquisimeto 1
Batam 1
Brasília 1
Cachoeira do Sul 1
Hanoi 1
Hong Kong 1
Itumbiara 1
Junín 1
Natal 1
Pirassununga 1
Recife 1
Santa Luzia 1
São Paulo 1
Totale 1.616
Nome #
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 158
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 137
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease 127
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 117
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 113
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 111
Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management 110
Reproducibility and transportability of the absence of incremental infectious adverse events in patients with higher anti-TNF drug levels 105
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 105
Elevated adherence to vaccination against SARS-CoV-2 among patients with Inflammatory Bowel Disease 87
Review article – esophageal reflux hypersensitivity: Non-GERD or still GERD? 86
Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques 75
Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment 73
Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD 71
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 66
Reduction of fecal calprotectin levels induced by a short-course of Escherichia coli Nissle is associated with a lower likelihood of disease flares in patients with ulcerative colitis in clinical remission 61
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 60
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 30
Totale 1.692
Categoria #
all - tutte 7.215
article - articoli 7.006
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 7 5 4 21 7 20 12 11
2021/2022178 7 4 9 11 8 19 9 36 19 19 12 25
2022/2023169 22 22 1 5 18 19 1 28 22 2 24 5
2023/2024146 2 14 1 23 17 20 9 0 7 4 24 25
2024/2025475 22 19 19 12 44 53 31 140 23 15 49 48
2025/2026300 103 18 92 84 3 0 0 0 0 0 0 0
Totale 1.692